The first ten years: achievements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996-2006

Hacker, Mariana A.; Kaida, Angela; Hogg, Robert S.; Bastos, Francisco I.

doi:10.1590/s0102-311x2007001500003

Cited by 50 publications

(57 citation statements)

References 83 publications

(101 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…conceptualized and measured and by a lack of definition of what should be considered optimal adherence 12 . BONOLO et al 2 review 43 articles on adherence to HAART.…”

mentioning

confidence: 99%

Risk-factors for non-adherence to antiretroviral therapy

Silva

Ximenes

Filho

et al. 2009

Rev. Inst. Med. trop. S. Paulo

View full text Add to dashboard Cite

SUMMARYCross-sectional study analyzed as case-control to identify risk factors for non-adherence to antiretroviral therapy. We studied 412 out-clinics HIV infected subjects of three public hospitals of Recife, Pernambuco. The objective was to examine the association between non-adherence to the antiretroviral therapy and biological, social-behavior and demographics and economic factors, factors related to the disease and/or treatment, factors related to life habits and depression symptoms. Variables significantly associated with non-adherence to antiretroviral therapy were: time elapsed since HIV diagnosis (p = 0.002), daily dose (p = 0.046), use of alcohol (p = 0.030) and past drug use (p = 0.048), and borderline p-values were found for educational level (p = 0.093) and family monthly income (p = 0.08). In the multivariable analysis, the factors that remained in the final model were family monthly income, time period with HIV infection and use of alcohol. No association was observed between non-adherence to antiretroviral therapy and gender, age, sexual orientation, marital status, educational level and place of residence.Based on our results and the local situation we suggest: assessment of social needs; training of partners and/or families on supporting adherence, creation of "adherence groups" to motivate and to reassure patients on the benefits of treatment; counseling and/or psychotherapy for alcohol drinkers.

show abstract

“…conceptualized and measured and by a lack of definition of what should be considered optimal adherence 12 . BONOLO et al 2 review 43 articles on adherence to HAART.…”

mentioning

confidence: 99%

Risk-factors for non-adherence to antiretroviral therapy

Silva

Ximenes

Filho

et al. 2009

Rev. Inst. Med. trop. S. Paulo

View full text Add to dashboard Cite

show abstract

“…Tabela 3 -Valores absolutos de triglicérides e colesterol total e com frações pré e pós-terapia antirretroviral (n = 113) 3 Inibidores da trascriptase reversa não análogos de nucleosídeos (ITRNN). 4 Inibidores de protease (IP).…”

Section: Discussionunclassified

“…Em meados da década de 1990 foi desenvolvida a terapia antirretroviral de alta potência (highly active antiretroviral therapy -HAART), modificando dramaticamente a mortalidade e aumentando a sobrevida dos pacientes HIV-positivo (3) . Entretanto, a HA-ART determina importantes efeitos colaterais, sendo a alteração do perfil lipídico (PL) um dos mais frequentes (1) .…”

Section: Introductionunclassified

DislipiDemias e Risco caRDiovasculaR em pacientes Hiv-positivo utilizanDo teRapia antiRRetRoviRal na Região oeste De santa cataRina

Lang¹,

Sanagiotto²,

Ferraz³

et al. 2012

J Bras Doenças Sex Transm

View full text Add to dashboard Cite

show abstract

“…Antiretroviral therapy (ART) reduces HIV-related morbidity and mortality, decreases viral load and spread of HIV, and can alter the risky behaviors of HIV-patients [20][21][22][23][24][25][26][27][28][29]. Expansion of ART into resource-limited countries has occurred in the last decade, yet coverage is still low in many parts of the world, including Eastern Europe, which only reports 23% ART coverage [30][31][32][33][34].…”

Section: Introductionmentioning

confidence: 99%

Antiretroviral therapy adherence and predictors to adherence in Albania: a cross-sectional study

Morrison

Rashidi

Sarnquist

et al. 2014

J Infect Dev Ctries

View full text Add to dashboard Cite

Introduction: The possibility of an HIV/AIDS epidemic in southeastern Europe (SEE) is not improbable. Thus, an understanding of the current issues surrounding HIV/AIDS care, specifically antiretroviral therapy (ART) adherence, in countries within SEE is critical. This study was conducted to determine the ART adherence characteristics of Albania's HIV-positive population. Methodology: This cross-sectional study reports initial demographic and adherence characteristics of patients receiving HIV/AIDS treatment in Albania. Retrospective review of pharmacy medications dispensed supplemented reported adherence behavior. Further, an adherence index was utilized to explore adherence more thoroughly.

show abstract

The first ten years: achievements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996-2006

Cited by 50 publications

References 83 publications

Risk-factors for non-adherence to antiretroviral therapy

Risk-factors for non-adherence to antiretroviral therapy

DislipiDemias e Risco caRDiovasculaR em pacientes Hiv-positivo utilizanDo teRapia antiRRetRoviRal na Região oeste De santa cataRina

Antiretroviral therapy adherence and predictors to adherence in Albania: a cross-sectional study

Contact Info

Product

Resources

About